The Exchange Offer was previously set to expire at 5:00 p.m., New York City time, on July 20, 2001.
Except for the absence of transfer restrictions under the federal securities laws applicable to the Series A Notes, the Series B Notes are identical to the Series A Notes.
As of July 20, 2001, holders of approximately $216,950,000 principal amount of Series A Notes have tendered Series A Notes pursuant to the Exchange Offer. United States Trust Company of New York is serving as the Exchange Agent in connection with the Exchange Offer.
DaVita is a leading provider of dialysis services for patients suffering from chronic kidney failure. The Company owns and operates kidney dialysis centers and home peritoneal dialysis programs domestically in 32 states, as well as Washington, D.C. It also provides acute hemodialysis services to inpatients at approximately 280 hospitals. As of May 31, 2001 we operated 487 outpatient dialysis facilities serving over 41,000 patients, including 3,400 patients in 35 centers under management.
SOURCE: DaVita Inc.
Contact: LeAnne Zumwalt, Investor Relations of DaVita Inc.,